Background Hepatitis B infection in injecting drug users is an important public health problem. Active immunization against hepatitis B is immunogenic and safe, but uptake rates in targeted vaccination programmes are low. This study was undertaken to identify factors associated with the uptake of hepatitis B vaccination in injecting drug users attending a needle exchange service.
Introduction
Hepatitis B is an important public health problem. Although it is often asymptomatic initially, the long-term complications include cirrhosis and hepatic cancer, diseases that kill about a million people worldwide each year. 1 The recognized modes of transmission are vertical transmission from mother to child, sexual contact, and exposure to blood and other body fluids. 2 It is endemic in much of the developing world, where between 8 and 10 per cent of the population are infected. 1 In most developed countries the prevalence is much lower (less than 1 per cent) 1 and the risks of transmission tend to be restricted to particular groups where exposure to blood is likely. 3 In England and Wales there was an increase in laboratory confirmed cases of hepatitis B from 1996 to 1998 of 43 per cent. 4 Injecting drug use is the largest single risk factor in England and Wales, accounting for 46 per cent of cases in 1998. 4 Evidence of past infection with hepatitis B virus, assessed by the presence of core antibody, in injecting drug users in England and Wales in 2000 was 21 per cent. 5 The prevalence of direct sharing of injecting equipment in current injectors was 31 per cent. 5 Active immunization against hepatitis B vaccine is immunogenic and safe. 3 Selective vaccination programmes are favoured by some low-endemicity countries including the United Kingdom, where national guidelines recommend vaccination for high-risk groups including injecting drug users. 6 Effective targeted vaccination with high uptake rates could do much to reduce the risks and reduce the prevalence of hepatitis B infection. However, if uptake is low, then a targeted policy will not be effective. Drug users may not avail themselves of traditional health services and many are not registered with family doctors. 7 Therefore, targeted vaccination programmes based in services for drug users may be appropriate. However, to date the targeted vaccination schemes have had little success. In 1993 only 10 per cent of services for drug users offered the vaccine, 8 and by 2000 only 22 per cent routinely offered vaccination against hepatitis B.
9 In 1995 and 1996, 27 per cent of injecting drug users attending drug agencies in England reported vaccination against hepatitis B and 13 per cent reported having received three doses. 10 By 1999, 29 per cent of injecting drug users reported having received vaccination, and of those receiving any vaccine, 49 per cent had received three injections.
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There are no published studies that explore the factors associated with injecting drug users starting or completing courses of hepatitis B vaccination. Given the poor coverage of vaccination reported in other studies, an understanding of these factors is essential if coverage is to be improved. This study was therefore conducted to identify these factors in the context of a needle exchange clinic that also offered hepatitis B vaccination.
Methods
This study was set in a drop-in service located in the centre of a large urban area in England and its satellite clinics. The service operates without appointments and offers a needle and syringe exchange, drug counselling, safe injecting advice, hepatitis B vaccination, and sexual health advice, including HIV testing.
The study was a retrospective cross-sectional survey of casenote data. The first 220 injecting opiate drug users attending the service between May and June 2000 were given written information about the study by the service staff and asked for written informed consent to have their clinic records reviewed. They were informed that the participation in the study was voluntary and that if they refused access to their records their relationship with the service would not be compromised.
For those clients who had no markers of hepatitis B infection or immunity, data for three main outcomes (offer of vaccine, acceptance of vaccine if offered and receipt of at least three doses if vaccination was started) were extracted from standard records. Demographic and risk factor data were also collected, including age, gender, ethnicity, social support, employment, literacy, mental ill-health, hepatitis C status, sharing of injecting equipment, both past and current, length of contact with the service, years spent injecting drugs, prescribed substitute or other drug treatments for addiction and prison sentences.
Statistical analyses were undertaken using SPSS for Windows version 10.0. Logistic regression analysis was used to determine odds ratios and 95 per cent confidence intervals for each of the independent variables and each of the three outcome measures. Multiple logistic regression analyses were used to control for confounding and produce adjusted odds ratios.
A further component of the study was to interview all staff who were involved in the hepatitis B vaccination programme to identify their views of the barriers and enablers to vaccination. Qualitative analyses of these data were performed using Fielding's Content Analysis method. 12 Ethical approval for the study was obtained from Nottingham Local Research Ethics Committee.
Results

Quantitative study
All clients who were invited to participate in the study gave consent for their records to be reviewed. Of the 211 who participated in the study, 207 (93.6 per cent) were known to be hepatitis B surface antigen negative. A total of 180 (87 per cent) were offered hepatitis B vaccine, 123 (59 per cent) received at least one dose of vaccine and 55 (27 per cent) received three or more doses.
Factors associated with being offered vaccination
In univariate analyses, those clients who were known to be hepatitis C positive, those who were currently sharing needles and those who were known to have literacy and mental health problems were less likely than others to be offered hepatitis B vaccination. When adjusted for confounding this difference persisted for those who were currently sharing needles and those with hepatitis C (Table 1) .
Factors associated with receiving one or more doses of vaccine
In univariate analyses current needle sharing and length of contact with the syringe and needle exchange service were associated with acceptance of at least one dose of vaccine, by those who had been offered vaccine ( Table 2) . The relationship between length of contact with the service and accepting vaccine takes the form of an inverted U-shaped curve, with those clients in contact with the service for between 1 and 2 years being most likely to accept vaccination.
In the multivariate analyses the associations with current needle sharing and length of contact with the service persist, and the client's age also shows an association, with decreasing likelihood of accepting vaccine with increasing age.
Factors associated with completion of vaccine course if started
In univariate analysis the only factor associated with completion of the course of vaccine was employment status, with unemployed people being less likely to complete the course than employed people. No factors were significant after adjusting for confounding.
Qualitative study
All five staff working at the centre agreed to be interviewed for the study.
Barriers to vaccine uptake
Staff reported that they believed the following factors acted as barriers to vaccine uptake:
• difficulties in contact tracing household contacts because of the confidential nature of the service;
• injecting drug users' chaotic lifestyles and their lack of awareness of the risks of hepatitis B;
• some staff had not being trained to screen for hepatitis B nor to administer the vaccine;
• the failure of other services such as drug treatment services, family doctors and the prison service to start or complete courses. Please note that in this study odds ratios should not be treated as estimates of relative risk because the outcomes of interest are common.
Enablers of vaccine uptake
Staff reported that they believed the following factors helped to improve vaccine uptake:
• improved co-ordination of the vaccine programme since a vaccine co-ordinator post had been established;
• training that enabled staff to deliver the vaccine in a flexible way to injecting drug users attending the service;
• increasing awareness of hepatitis B vaccination by administering vaccine in a variety of venues and settings to increase uptake in high-risk groups such as the homeless and transient injecting drug users, sex workers and younger people;
• improved monitoring of vaccine courses;
• reminders in injecting drug users' records to prompt next doses;
• accelerated vaccine courses;
• the adoption by staff of a positive attitude to injecting drug users' primary health care needs.
Discussion
To our knowledge, this is the first study reporting factors associated with vaccination against hepatitis B in injecting drug users. The study has also gained insight into reasons for poor uptake through qualitative interviews with staff.
No clients refused to participate in the study so the sample is likely to be representative of clients attending similar needle exchange services. However, the study design did not enable us to examine uptake in injecting drug users who did not attend the service. It might be expected that the uptake of vaccine in such clients would be extremely low. The results are dependent on the quality of the information held in records. The centre used standard forms for recording information on clients and few data were missing, minimizing the possibility of measurement biases. However, some questions may have been interpreted differently by different subjects, particularly those about sharing injecting equipment.
This study was conducted in only one setting and the proportion of clients taking up and completing courses of hepatitis B vaccination was higher than that reported elsewhere.
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Although caution should be exercised in generalizing to other settings, the factors associated with vaccination may be applicable to other settings where there are concerted campaigns to improve vaccine uptake in injecting drug users.
The findings show that drug services such as needle exchange centres can play an important part in vaccination of injecting drug users. Needle exchanges tend to attract drug users both in and out of contact with other drug agencies, thereby having the potential to target more of the drug-using population at risk of acquiring hepatitis B infection. However, even in the context of a concerted campaign to maximize vaccination a high proportion of drug users attending the service remained at risk of hepatitis B infection.
Staff reported a number of issues that they perceived as barriers to vaccine uptake:
• contact tracing household contacts because of the confidential nature of the service;
• operational issues such as some staff being unable to screen for hepatitis B or administer the vaccine;
• the failure of other services such as drug treatment services, family doctors and the prison service to start or complete courses.
Co-infection with hepatitis B and hepatitis C is associated with more severe liver disease than infection with hepatitis C alone 13 and carries an increased risk of hepatocellular cancer.
14 Thus, the fact that those clients who were known to have hepatitis C were less likely to be offered hepatitis B vaccination is of concern. The reason for this finding is unclear but it may represent confusion about the need for vaccination in this group or assumptions that it has been offered by medical staff who are seeing the patient in relation to their hepatitis C diagnosis. It is also of concern that those who currently share needles are less likely to be offered vaccination. These clients may have a tendency to lead more chaotic lifestyles that prevent them from effectively engaging with services. Thus, those people at highest risk remain unprotected. The reasons for this need to be explored further and interventions devised to try to increase the number of these people being offered vaccination. Those who currently shared needles were also less likely to accept vaccination, if offered. This may reflect a poorer understanding of the risks posed by sharing needles. The relationship between length of contact with the service and acceptance of vaccination is interesting. Those who have been in contact with the service for between 1 and 2 years were most likely to accept vaccination, whereas those with shorter and longer lengths of contact with the service were less likely to accept it. Those who have been in contact with the service for a short time may not have built a sufficient level of trust, or may not be as aware of the risks of hepatitis B. The reason for the reduced acceptance amongst those with longer periods of contact is less easy to explain. Older clients were less likely to accept vaccination, a finding that is at variance with that of Lamagni et al., 11 who found the median age in the vaccinated of 29 years and the non-vaccinated group of 28 years. The significance of this finding is unclear, but it may suggest that older injecting drug users perceive their risks of contracting hepatitis B to be low. Lamagni et al. 11 also found that the vaccinated had a significantly longer injecting career than the unvaccinated, a factor that was not significant in the current study.
After adjusting for confounding, no factors could be found that were significantly associated with completion of three doses of vaccine. This may well be because the numbers in this analysis were small.
The fact that the clients who were most at risk of being exposed to hepatitis B infection (those who continue to share injecting equipment) were the least likely to have been offered vaccine and to accept vaccine if offered, is particularly worrying. This highlights the need to increase efforts to vaccinate this group. A high proportion (55 per cent) of injecting drug users in this study had been in prison. Prison represents an important opportunity to offer vaccine to this group of clients. Injecting drug users often have contact with a variety of other health and social services and also with the prison system. At present, the opportunity to offer vaccine is often not taken in these other settings. The staff perceived there to be a relative lack of involvement and sharing of information between drug treatment services and other agencies in contact with injecting drug users, including general practitioners. In addition, prison vaccination provision was generally perceived as poor although many clients served custodial sentences.
This client group tends to have chaotic lifestyles, making it difficult for them to attend preventive health services. When injecting drug users do attend services such as needle exchange centres, organizational systems to ensure that they are made aware of the risks of hepatitis B and that vaccine is offered are essential. These systems include staff training, good record keeping and reminder systems. Good communication within and between services is a key element in ensuring optimal uptake of vaccination. Appropriate communication of the risks of hepatitis B infection is also essential.
If a targeted vaccination strategy is to be successful, the factors associated with vaccination need to be understood. This study elucidates some of these factors. Strategies should be developed to increase vaccination rates amongst injecting drug users. Particular attention should be paid to increasing uptake in those who continue to inject, as this group is at high risk of contracting hepatitis B. This study suggests that uptake in this group is particularly poor. If successful strategies cannot be developed, then serious consideration must be given to a universal vaccination programme for hepatitis B.
